Search Results - "Orekhov, A N"

Refine Results
  1. 1

    Vascular smooth muscle cell in atherosclerosis by Chistiakov, D. A., Orekhov, A. N., Bobryshev, Y. V.

    Published in Acta Physiologica (01-05-2015)
    “…Vascular smooth muscle cells (VSMCs) exhibit phenotypic and functional plasticity in order to respond to vascular injury. In case of the vessel damage, VSMCs…”
    Get full text
    Journal Article
  2. 2

    Effects of shear stress on endothelial cells: go with the flow by Chistiakov, D. A., Orekhov, A. N., Bobryshev, Y. V.

    Published in Acta Physiologica (01-02-2017)
    “…Haemodynamic forces influence the functional properties of vascular endothelium. Endothelial cells (ECs) have a variety of receptors, which sense flow and…”
    Get full text
    Journal Article
  3. 3

    Lipid composition of circulating multiple-modified low density lipoprotein by Zakiev, E R, Sukhorukov, V N, Melnichenko, A A, Sobenin, I A, Ivanova, E A, Orekhov, A N

    Published in Lipids in health and disease (24-08-2016)
    “…Atherogenic modified low- density lipoprotein (LDL) induces pronounced accumulation of cholesterol and lipids in the arterial wall, while native LDL seems to…”
    Get full text
    Journal Article
  4. 4

    Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats by Liu, C., Wang, L., Zhu, R., Liu, H., Ma, R., Chen, B., Li, L., Guo, Y., Jia, Q., Shi, S., Zhao, D., Mo, F., Zhao, B., Niu, J., Fu, M., Orekhov, A.N., Brömme, D., Gao, S., Zhang, D.

    Published in Osteoporosis international (01-02-2019)
    “…Summary Rehmanniae Radix Preparata (RRP) improves bone quality in OVX rats through the regulation of bone homeostasis via increasing osteoblastogenesis and…”
    Get full text
    Journal Article
  5. 5

    Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis by Poznyak, A V, Kashirskikh, D A, Postnov, A Y, Popov, M A, Sukhorukov, V N, Orekhov, A N

    “…In the modern world, cardiovascular diseases have a special place among the most common causes of death. Naturally, this widespread problem cannot escape the…”
    Get full text
    Journal Article
  6. 6

    An update on the tools for creating transgenic animal models of human diseases - focus on atherosclerosis by Volobueva, A S, Orekhov, A N, Deykin, A V

    “…Animal models of diseases are invaluable tools of modern medicine. More than forty years have passed since the first successful experiments and the spectrum of…”
    Get full text
    Journal Article
  7. 7

    Peculiarities of cell composition and cell proliferation in different type atherosclerotic lesions in carotid and coronary arteries by Orekhov, A.N, Andreeva, E.R, Andrianova, I.V, Bobryshev, Y.V

    Published in Atherosclerosis (01-10-2010)
    “…Abstract Increased cell proliferation in early atherosclerotic lesions is recognized as an essential event in atherogenesis but the levels of cell…”
    Get full text
    Journal Article
  8. 8

    Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability by Chistiakov, D. A., Orekhov, A. N., Bobryshev, Y. V.

    Published in Acta Physiologica (01-03-2015)
    “…Atherosclerosis is a continuous pathological process that starts early in life and progresses frequently to unstable plaques. Plaque rupture leads to…”
    Get full text
    Journal Article
  9. 9

    The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases by Babintseva, Ya D, Camont, L, Chapman, J, Lhomme, M, Karagodin, V P, Kontush, A, Orekhov, A N

    Published in Terapevtic̆eskii arhiv (01-01-2016)
    “…Increasing the human plasma concentration of high-density lipoproteins (HDL) may be part of strategy for control of cardiovascular diseases (CVD). HDL…”
    Get full text
    Journal Article
  10. 10

    Epigenetic factors in atherogenesis: MicroRNA by Smirnova, A. V., Sukhorukov, V. N., Karagodin, V. P., Orekhov, A. N.

    “…MicroRNAs (miRNAs) are small (~22 nucleotides in length) noncoding RNA sequences regulating gene expression at the posttranscriptional level. MicroRNAs bind…”
    Get full text
    Journal Article
  11. 11

    The complexity of cell composition of the intima of large arteries: focus on pericyte-like cells by Orekhov, Alexander N, Bobryshev, Yuri V, Chistiakov, Dimitry A

    Published in Cardiovascular research (01-09-2014)
    “…Pericytes, which are also known as Rouget cells or perivascular cells, are considered to represent a likely distinct pool of vascular cells that are extremely…”
    Get full text
    Journal Article
  12. 12

    Animal models of human atherosclerosis: current progress by Poznyak, A V, Silaeva, Y Y, Orekhov, A N, Deykin, A V

    “…Atherosclerosis retains the leading position among the causes of global morbidity and mortality worldwide, especially in the industrialized countries. Despite…”
    Get full text
    Journal Article
  13. 13

    Coordination in gene expression during atherogenesis by Shchelkunova, T. A., Morozov, I. A., Rubtsov, P. M., Samokhodskaya, L. M., Sobenin, I. A., Orekhov, A. N., Smirnov, A. N.

    Published in Biochemistry (Moscow) (01-08-2013)
    “…General tendencies in the regulation of gene expression during atherogenesis were investigated using correlation analysis for 34 mRNA species of several…”
    Get full text
    Journal Article
  14. 14

    Impaired tolerance of monocyte-macrophages to lipopolysaccharide in patients with coronary atherosclerosis by Chegodaev, E. S., Nikiforov, N. G., Popov, M. A., Shumakov, D. V., Zybin, D. I., Orekhov, A. N.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (22-09-2024)
    “…Atherosclerosis is a chronic disease in which lipids, cells and various proteins accumulate in the walls of the arteries, forming atherosclerotic plaques. The…”
    Get full text
    Journal Article
  15. 15

    Phytoestrogen‐Rich Natural Preparation for Treatment of Climacteric Syndrome and Atherosclerosis Prevention in Perimenopausal Women by Kirichenko, T. V., Myasoedova, V. A., Orekhova, V. A., Ravani, A. L., Nikitina, N. A., Grechko, A. V., Sobenin, I. A., Orekhov, A. N.

    Published in Phytotherapy research (01-08-2017)
    “…The present study evaluated the risks and benefits of phytoestrogen treatment in healthy perimenopausal women in relation to the dynamics of climacteric…”
    Get full text
    Journal Article
  16. 16

    Low-density lipoprotein modification occurring in human plasma: Possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification by Tertov, V.V, Kaplun, V.V, Sobenin, I.A, Orekhov, A.N

    Published in Atherosclerosis (01-05-1998)
    “…We previously found in human blood a fraction of low-density lipoprotein (LDL) that is characterized by a reduced content of sialic acid. Desialylated LDL also…”
    Get full text
    Journal Article
  17. 17

    Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases by Bogatyreva, A. I., Gerasimova, E. V., Kirichenko, T. V., Markina, Yu. V., Popkova, T. V., Shalygina, M. V., Tolstik, T. V., Markin, A. M., Orekhov, A. N.

    Published in Doklady. Biochemistry and biophysics (01-08-2024)
    “…The pathogenesis of immunoinflammatory rheumatic diseases (IRDs) is based on chronic inflammation, one of the key mechanisms of which may be abnormal…”
    Get full text
    Journal Article
  18. 18

    Deglycosylation of apo B-containing lipoproteins increase their ability to aggregate and to promote intracellular cholesterol accumulation in vitro by Aksenov, D. V., Medvedeva, L. A., Skalbe, T. A., Sobenin, I. A., Tertov, V. V., Gabbasov, Z. A., Popov, E. V., Orekhov, A. N.

    Published in Archives of physiology and biochemistry (01-12-2008)
    “…Sub-fractions of all apo B-100 containing lipoproteins (low density lipoproteins, very low density lipoproteins and intermediate density lipoproteins) with…”
    Get full text
    Journal Article
  19. 19

    Pro-inflammatory activation of monocytes in patients with immunoinflammatory rheumatic diseases by Bogatyreva, A. I., Gerasimova, E. V., Kirichenko, T. V., Markina, Yu. V., Popkova, T. V., Shalygina, M. V., Tolstik, T. V., Markin, A. M., Orekhov, A. N.

    “…The pathogenesis of immunoinflammatory rheumatic diseases (IRDs) is based on chronic inflammation, one of the key mechanisms of which may be abnormal…”
    Get full text
    Journal Article
  20. 20